According to the World Health Organization statistics published in 2018, Sepsis affects an estimated of 30 million people worldwide with a death toll of approximately 6 million annually. Sepsis arises due to the hyper activity of the immune system in response to the infectious diseases. The chemicals released in the body damages the tissues and organs of a patient, thereby leading to organ failure and eventually death.
In response to this, medical professionals and organizations have adopted the sepsis diagnostic as a primitive procedure in the treatment of infectious diseases and wide range of chronic disorders. Patients suffering with kidney disease, liver cirrhosis, HIV/AIDS, cancer, no spleen and autoimmune diseases, and neonates, pregnant women, and elderly people are highly vulnerable to the development of sepsis.
The global sepsis diagnostic market is primarily driven by the expanding geriatric population, prevalence of infectious diseases, and increasing investment in diagnostic equipment research. The global sepsis diagnostic market is expected to expand at a significant growth rate during the forecast period.
North America contributed the largest share to the global sepsis diagnostic market in 2019 and is anticipated to be the dominating geography during the forecast period. Presence of analytical equipment and diagnostic equipment manufacturers and prevalence of infectious diseases are the major factors driving the sepsis diagnostic market in North America.
Asia Pacific contributed a significant share to the global market in 2019 owing to increasing investment focused on strengthening the medial equipment manufacturing industry in major economies such as China, India and Southeast Asian countries.
Expanding geriatric population, increasing neonatal inpatient count, and rising awareness regarding early diagnostic and treatment for infectious diseases are the key parameters shaping the sepsis diagnostic market in Asia Pacific.
The report titled “Sepsis Diagnostic Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global sepsis diagnostic market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Danaher Corporation reported revenues of USD 17,911.1 million in 2019 and the product segment analysis of the company indicates that Life Sciences business segment of the company dominated revenue in 2019.
The global sepsis diagnostic market is segmented based on product type, technology, pathogen type, testing type, and geography. Based on product type, the global sepsis diagnostic market is segmented into instruments, blood culture media, assay kits and reagents, and others. Based on technology, the global sepsis diagnostic market is segmented onto microbiology, molecular diagnostics, immunoassays, and flow cytometry. Based on pathogen type, the global sepsis diagnostic market is segmented into bacterial sepsis, fungal sepsis, and others. The bacteria sepsis pathogens are sub-segmented into gram-positive bacteria, and gram-negative bacteria. Based on testing type, the global sepsis diagnostic market is segmented into laboratory testing, and PoC testing. Based on geography, the global sepsis diagnostic market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on sepsis diagnostic equipment and technology. Further, market share of prominent companies in the global sepsis diagnostic market would also be estimated. For instance, Danaher Corporation operates through three business segments namely Life Science, Diagnostics, and Environmental & Applied Solutions. The sepsis diagnostic products are delivered under Diagnostics business segment of the company with revenue contribution of US$ 6.6 billion in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the sepsis diagnostic device manufacturing companies and technology providers. Furthermore, the global sepsis diagnostic market study would take into consideration the participants engaged throughout the ecosystem of the market, along with their contribution.
Product portfolio would focus on all the products under the sepsis diagnostic business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global sepsis diagnostic market.
Major players operating the global sepsis diagnostic market include Amara Health Analytics, Becton, Dickinson and Company, bioMérieux SA, Bruker Corporation, Cerner Corporation, Danaher Corporation, Epic Systems Corporation, GE Healthcare, Koninklijke Philips N.V., Luminex Corporation, McKesson Corporation, Roche Diagnostics, Sysmex Corporation, Thermo Fisher Scientific, Inc., and Wolters Kluwer N.V.
By Technology
By Product
By testing type
By Pathogen
By Geography
North America is the principal contributor to the global Sepsis Diagnostic market.
The base year considered in Sepsis Diagnostic market report is 2022.
The major active players are Amara Health Analytics, Becton, Dickinson and Company, bioMérieux SA, Bruker Corporation, Cerner Corporation, Danaher Corporation, Epic Systems Corporation, GE Healthcare, Koninklijke Philips N.V., Luminex Corporation, McKesson Corporation, Roche Diagnostics, Sysmex Corporation, Thermo Fisher Scientific, Inc., and Wolters Kluwer N.V..
The global Sepsis Diagnostic market segmented on the basis of product type, technology, pathogen type, testing type, and geography
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved